Results 161 to 170 of about 18,985 (204)

Zoledronic Acid Treatment for Diffuse Sclerosing Osteomyelitis of the Mandible: A Case Report and Literature Review of Antiresorptive Therapy. [PDF]

Cureus
Niimi T, Miwa R, Kitagawa K, Natsume N, Sakamoto Y.   +4 more
europepmc   +1 more source

Titanium Implants Functionalized with Zoledronic Acid Associated with Ruterpy Accelerate Peri-Implant Repair in Healthy and Osteoporotic Rats. [PDF]

Biomimetics (Basel)
Paludetto LV, Breseghello I, Frasnelli SCT, Batista FRS, Botacin PR, Antoniali C, Lisboa-Filho PN, Okamoto R.   +7 more
europepmc   +1 more source

Clinical features, treatment, and prognosis of zoledronic acid-induced uveitis. [PDF]

Eye (Lond)
Wu Z, Sun W, Zhou Y, Wang C.
europepmc   +1 more source

Estrogen prevents anti-tumor effects of Zoledronic acid in breast cancer through the NK and CD8+T cell PD-1/PD-L1 axes

George C, Zhou J, Canuas-Landero V, Lefley D, Hughes R, Thistletwaite F, Wilson C, Holen I, Brown J, Dunning M, Danson S, Winter M, Quayle L, Muthana M, Ottewell P.   +14 more
europepmc   +1 more source

Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth With Primary and Secondary Skeletal Fragility.

J Clin Endocrinol Metab
Stoffers AJ, Mancilla EE, Levine MA, Mayer M, Monk HM, Rosano J, Weber DR.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Zoledronic Acid

Drugs, 2012
Keri Wellington, Wellington Keri, Goa Karen L   +2 more
exaly   +10 more sources

Zoledronic acid

Expert Opinion on Drug Safety, 2010
Both bone metastases and fragility fractures due to bone loss result in considerable morbidity affecting quality of life and independence as well as placing complex demands on healthcare resources. Zoledronic acid is a widely used intravenous bisphosphonate that reduces this skeletal morbidity in both benign and malignant conditions.The incidence ...
Robert, Coleman, Roger, Burkinshaw, Matthew, Winter, Helen, Neville-Webbe, Jim, Lester, Emma, Woodward, Janet, Brown   +6 more
  +6 more sources

Zoledronic Acid

Drugs, 2001
Zoledronic acid (zoledronate) is a new generation bisphosphonate that inhibits osteoclast bone resorption. It was much more potent than other bisphosphonates at inhibiting 1,25-dihydroxyvitamin D3-induced hypercalcaemia in a rat model and calcium release in vitro.
S M, Cheer, S, Noble
openaire   +2 more sources

Zoledronic Acid and Angiogenesis

Clinical Cancer Research, 2007
To the Editors: In a recent issue of Clinical Cancer Research , Santini and co-workers ([1][1]) assert that zoledronic acid (ZA) may inhibit several antiangiogenic-related cascades and its metronomic administration could represent a new potential therapy targeting the endothelial-tumor ...
Gianluigi, Ferretti, Alessandra, Fabi, Paolo, Carlini, Paola, Papaldo, Alessandra, Felici, Silverio, Tomao, Francesco, Cognetti   +6 more
openaire   +2 more sources